News
Sarepta (SRPT) plans to continue Elevidys shipments for Duchenne muscular dystrophy, despite FDA request not to do so after ...
1d
TipRanks on MSNJPMorgan, Starbucks, HPE, Sarepta, Elevance: Trending by AnalystsAnalysts are intrested in these 5 stocks: ( ($JPM) ), ( ($SBUX) ), ( ($HPE) ), ( ($SRPT) ) and ( ($ELV) ). Here is a breakdown of their recent ...
Sarepta rebuffed a call from the Food and Drug Administration to halt all shipments of its gene therapy for Duchenne muscular ...
One of biotech’s highest fliers, Sarepta Therapeutics, lost more than a third of its market value on Friday after executives said that one of its experimental gene-replacement therapies was linked to ...
Detailed price information for Sarepta Therapeutics (SRPT-Q) from The Globe and Mail including charting and trades.
Why didn’t federal prosecutors charge Sean Combs with more obvious, easy-to-prove offenses? Because they can’t help themselves?
The Milwaukee Bucks got everyone's attention with their outside-the-box maneuvers July 1, but national writers aren't sure they'll work.
Ukraine received mixed results during the 2025 NATO summit. Given this ambiguity, time will tell how the NATO-Ukraine relationship will unfold.
Review quarterly and annual revenue, net income, and cash flow for Sarepta Therapeutics Inc (SRPT:XMEX) stock through the last fiscal year.
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on June 30, 2025 that were previously approved by the Compensation ...
Recent discussions on X about AST SpaceMobile (ASTS) have been buzzing with activity, largely driven by the company's latest financial maneuvers and analyst coverage. Many users have pointed out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results